FindMyKOL

David Ettinger, MD

Enriched profile

Alex Grass professor of Oncology · Johns Hopkins School of Medicine

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Lutherville, MD · Northeast · United StatesSpecialtyMedical OncologyFocusLung Cancer (NSCLC/SCLC)+3
Last active 2023FindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPayments2022–2023NIH funding1985–1997Why? →

David Ettinger is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 13 Nov 2026

Overview

Updated 16 Nov 2026

David Ettinger, M.D., is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (1985–1997).

  • Top research focus: Lung Cancer (NSCLC/SCLC)
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 16 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)2 trialsAdenocarcinoma of Lung1 trialSmall Cell Lung Carcinoma1 trialThymoma1 trial

Research focus

OpenAlex concept fingerprint
Lung Cancer (NSCLC/SCLC)Adenocarcinoma of LungSmall Cell Lung CarcinomaThymoma

Drugs & molecules

across trials, industry payments and publications
Spevigogeneric · SpesolimabClinical trials—Industry payments2Publications—Inlytageneric · AxitinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsClinical trials2Industry payments—Eastern Cooperative Oncology GroupClinical trials1Industry payments—Pfizer Inc.Clinical trials—Industry payments1Radiation Therapy Oncology GroupClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2022–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 1985–1997

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Nov 2026

2 companies reported payments to CMS in program years 2022–2023. These are public disclosures, not judgments. The latest:

NIH funding

Updated 13 Nov 2026

6 NIH research awards on record, funded 1985–1997 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 13 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.